Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: Are class solutions obsolete?

被引:1
|
作者
Everitt, S. [1 ,4 ]
Schneider-Kolsky, M. [4 ]
Yuen, K. [3 ]
Budd, R. [4 ]
Mac Manus, M. [2 ]
机构
[1] Monash Univ, Peter MacCallum Canc Ctr, Dept Radiat Therapy, Melbourne, Vic 8006, Australia
[2] Monash Univ, Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic 8006, Australia
[3] Monash Univ, Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic 8006, Australia
[4] Monash Univ, Dept Med Imaging & Radiat Sci, Melbourne, Vic 8006, Australia
关键词
dose optimization; non-small-cell lung cancer; positron emission tomography; three-dimensional conformal radiation therapy;
D O I
10.1111/j.1440-1673.2008.01937.x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study investigated the maximum theoretical radiation dose that could safely be delivered to 20 patients diagnosed with non-small-cell lung cancer. Two three-dimensional conformal radiation therapy (RT) class-solution techniques (A and B) and an individualized three-dimensional conformal RT technique (C) were compared at the standard dose of 60 Gy (part I). Dose escalation was then attempted for each technique successfully at 60 Gy, constrained by predetermined limits for lung and spinal canal (part II). Part I and part II data were reanalysed to include oesophageal dose constraints (part III). In part I, 60 Gy was successfully planned using techniques A, B and C in 19 (95%), 18 (90%) and 20 (100%) patients, respectively. The mean escalated dose attainable for part II using techniques A, B and C were 76.4, 74 and 97.8 Gy, respectively (P < 0.0005). One (5%) patient was successfully planned for 120 Gy using techniques A and B, whereas four (20%) were successfully planned using technique C. Following the inclusion of additional constraints applied to the oesophagus in part III, the amount of escalated dose remained the same for all patients who were successfully planned at 60 Gy apart from two patients when technique C was applied. In conclusion, individualized three-dimensional conformal RT facilitated greater dose conformation and higher escalation of dose in most patients. With modern planning tools, simple class solutions are obsolete for conventional dose radical RT in non-small-cell lung cancer. Highly individualized conformal planning is essential for dose escalation.
引用
收藏
页码:168 / 177
页数:10
相关论文
共 50 条
  • [41] Dose-Response Relationship Between Radiation Therapy and Loss of Lung Perfusion Comparing Positron Emission Tomography and Dual-Energy Computed Tomography in Non-Small Cell Lung Cancer Reply
    Milano, Michael T.
    Mavroidis, Panayiotis
    Yorke, Ellen
    Ryckman, Jeff
    Kong, Feng-Ming
    Grimm, Jimm
    Marks, Lawrence B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (04): : 1145 - 1146
  • [42] Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer
    Xu Na
    Wang Mengzhao
    Zhu Zhaohui
    Zhang Yingqiang
    Jiao Yang
    Fang Weigang
    中华医学杂志(英文版), 2014, 127 (04) : 607 - 613
  • [43] Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer
    Xu Na
    Wang Mengzhao
    Zhu Zhaohui
    Zhang Yingqiang
    Jiao Yang
    Fang Weigang
    CHINESE MEDICAL JOURNAL, 2014, 127 (04) : 607 - 613
  • [44] Radiation dose escalation in stage III non-small-cell lung cancer
    Terakedis, Breanne
    Sause, William
    FRONTIERS IN ONCOLOGY, 2011, 1
  • [45] Computed tomography and positron emission tomography-staged cN0 non-small cell lung cancer
    Kuroda, Hiroaki
    Nakada, Takeo
    Oya, Yuko
    Takahashi, Yusuke
    Shirai, Syn
    Matsui, Takuya
    Nakanishi, Keita
    Matsusita, Hirokazu
    Sakakura, Noriaki
    VIDEO-ASSISTED THORACIC SURGERY, 2020, 5 : 1 - 7
  • [46] Integrated positron emission tomography/computed tomography in patients with non-small cell lung cancer - Normal variants and pitfalls
    Truong, MT
    Erasmus, JJ
    Macapinlac, HA
    Marom, EM
    Mawlawi, O
    Gladish, GW
    Sabloff, BS
    Bruzzi, JE
    Munden, RF
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2005, 29 (02) : 205 - 209
  • [47] The Role Of Positron Emission Tomography - Computed Tomography (PET/CT) In The Prognosis Of Patients With Non Small Cell Lung Cancer (NSCLC)
    Tesfaye, A.
    Mozayen, M.
    Sarangi, M.
    Nagpal, S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S295 - S295
  • [48] Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer - Reply
    Scott, AM
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (05) : 237 - 237
  • [49] The role of positron emission tomography in mediastinal lymph node staging of non-small-cell lung cancer
    Melek, Huseyin
    Kavakli, Kuthan
    Gunluoglu, M. Zeki
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 19 (03): : 480 - 481
  • [50] Overestimation of the prognostic significance of SUV measurement by positron emission tomography for non-small-cell lung cancer
    Atkins, CD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6799 - 6800